Crocker Ventures is an independent, privately held life science and healthcare investment firm that funds promising seed- and early-stage life science companies in four primary areas: biotechnology/pharmaceuticals, medical devices, drug delivery and diagnostics. We are committed to identifying companies with strong intellectual property positions and significant growth potential that meet large, unmet market needs, and providing them with the capital and operating perspective they need to reach their full potential.

Unlike conventional private equity firms, Crocker Ventures is internally funded. Without the constraints of limited partner timelines and expectations, we deploy patient capital and determine company by company the optimal balance of near- and long-term results—for the benefit of both entrepreneurs and investors.

The Crocker Ventures portfolio includes:

• Investment portfolio, firms in which Crocker Ventures owns a minority equity position, run by independent management teams

• Operating portfolio, firms in which Crocker Ventures owns a majority equity position and provides a significant operational contribution

Crocker Ventures portfolio companies benefit from the entrepreneurial expertise of our founder and managing director, Gary L. Crocker who for more than three decades has played a major role in the creation of companies that have established global leadership in innovative industry niches. We have also established deep and broad networks of funding and infrastructure support across all stages of organizational development—from start up to exit.